Synergy Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,194
Closed -$63.5K 623
2024
Q4
$63.5K Buy
+2,194
New +$59.5K ﹤0.01% 258
2024
Q3
Sell
-164,417
Closed -$4.6M 169
2024
Q2
$4.6M Sell
164,417
-59,067
-26% -$1.63M 0.72% 37
2024
Q1
$6.2M Buy
223,484
+67,842
+44% +$1.88M 1.05% 25
2023
Q4
$4.48M Buy
155,642
+17,628
+13% +$533K 0.8% 32
2023
Q3
$4.58M Buy
138,014
+129,929
+1,607% +$4.59M 0.91% 31
2023
Q2
$297K Buy
8,085
+932
+13% +$36.3K 0.07% 75
2023
Q1
$292K Sell
7,153
-134
-2% -$5.79K 0.07% 94
2022
Q4
$373K Buy
7,287
+236
+3% +$11.3K 0.1% 80
2022
Q3
$308K Buy
+7,051
New +$343K 0.08% 81
2021
Q3
Sell
-36,124
Closed -$1.42M 122
2021
Q2
$1.42M Sell
36,124
-38,128
-51% -$1.48M 0.38% 56
2021
Q1
$2.69M Buy
74,252
+4,450
+6% +$158K 0.81% 47
2020
Q4
$2.57M Buy
+69,802
New +$2.56M 0.81% 45

Other funds holding PFE

Synergy Asset Management's PFE Position: Q1 2025 in Review

Synergy Asset Management sold out of Pfizer (PFE) in Q1 2025, closing a stake of 2,194 shares — an estimated $63.5K sold.

Synergy Asset Management first reported a position in PFE in Q4 2020 and held it in 12 quarters. The position peaked at $6.2M in Q1 2024. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Synergy Asset Management reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Synergy Asset Management sold 2,194 Pfizer shares in Q1 2025, an estimated $63.5K.
  • Synergy Asset Management first reported a position in Pfizer in Q4 2020 and held it in 12 quarters.
  • Synergy Asset Management's Pfizer position peaked at $6.2M in Q1 2024.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Synergy Asset Management's 13F filing for Q1 2025, filed 22 Apr 2025.